Terms: = Cervical cancer AND PAX8, ENSG00000125618, 7849
52 results:
1. Health-related quality of life associated with different cervical cancer therapies received by patients in two Nigerian tertiary hospitals.
Samaila A; Biambo AA; Usman N; Aliyu UM; Abdullahi A; Adibe MO
Afr Health Sci; 2023 Sep; 23(3):261-268. PubMed ID: 38357130
[TBL] [Abstract] [Full Text] [Related]
2. Metastatic recurrence of lung adenocarcinoma in thyroid clinically masquerading as primary thyroid cancer and immunohistochemically positive for thyroglobulin.
Yorita K; Hokimoto N; Tanida N; Matsuoka H
BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37208007
[TBL] [Abstract] [Full Text] [Related]
3. GWAS meta-analyses clarify the genetics of cervical phenotypes and inform risk stratification for cervical cancer.
Koel M; Võsa U; Jõeloo M; Läll K; Gualdo NP; Laivuori H; Lemmelä S; ; Daly M; Palta P; Mägi R; Laisk T
Hum Mol Genet; 2023 Jun; 32(12):2103-2116. PubMed ID: 36929174
[TBL] [Abstract] [Full Text] [Related]
4. SOX17: A Highly Sensitive and Specific Immunomarker for Ovarian and Endometrial Carcinomas.
Zhang X; Yao J; Niu N; Li X; Liu Y; Huo L; Euscher ED; Wang H; Bell D; Sood AK; Wang G; Lawson BC; Ramalingam P; Malpica A; Sahin AA; Ding Q; Liu J
Mod Pathol; 2023 Feb; 36(2):100001. PubMed ID: 36853778
[TBL] [Abstract] [Full Text] [Related]
5. Identifying SOX17 as a Sensitive and Specific Marker for Ovarian and Endometrial Carcinomas.
Shaker N; Chen W; Sinclair W; Parwani AV; Li Z
Mod Pathol; 2023 Jan; 36(1):100038. PubMed ID: 36788073
[TBL] [Abstract] [Full Text] [Related]
6. Mesonephric Adenocarcinoma and Mesonephric-like Adenocarcinoma of the Urinary Tract.
Xing D; Liang SX; Gao FF; Epstein JI
Mod Pathol; 2023 Jan; 36(1):100031. PubMed ID: 36788068
[TBL] [Abstract] [Full Text] [Related]
7. Primary HPV-Associated Enteric-Type Adenocarcinoma of Vagina: A Case Report.
Felicelli C; Strickland A; Wei JJ
Int J Surg Pathol; 2023 Oct; 31(7):1393-1397. PubMed ID: 36694422
[TBL] [Abstract] [Full Text] [Related]
8. Membranous and nuclear staining of CLDN18 in HPV-independent and HPV-associated endocervical adenocarcinomas.
Du X; Hu Y; Ji X; Sui L; Zheng Q; Song K; Lv T; Chen Y; Zhao H; Dai S; Zhao P; Yao Q
Cancer Med; 2023 Jan; 12(2):1441-1450. PubMed ID: 35861118
[TBL] [Abstract] [Full Text] [Related]
9. An unusual case of carcinoma with mesonephric-like features with a spindle cell component diagnosed on the Pap test of the uterine cervix: Cytomorphologic and immunophenotypic features and diagnostic pitfalls.
Besharati S; Liu-Jarin X; Chen X; Cimic A
Diagn Cytopathol; 2022 Nov; 50(11):E325-E329. PubMed ID: 35778908
[TBL] [Abstract] [Full Text] [Related]
10. Mucinous Tumor Coexisting With Mesonephric-like Proliferation/Tumor in the Ovary: A Novel Association.
Nilforoushan N; Liu L; Cheang G; Sui AC; Andersen J; Finkelman BS; Liu Y; Nasseri-Nik N; Vang R; Ronnett BM; Song W; Xing D
Am J Surg Pathol; 2022 Aug; 46(8):1095-1105. PubMed ID: 35405716
[TBL] [Abstract] [Full Text] [Related]
11. Mutational analysis using next generation sequencing in pediatric thyroid cancer reveals BRAF and fusion oncogenes are common.
Newfield RS; Jiang W; Sugganth DX; Hantash FM; Lee E; Newbury RO
Int J Pediatr Otorhinolaryngol; 2022 Jun; 157():111121. PubMed ID: 35397361
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathological and prognostic significance of immunophenotypic characterization of endocervical adenocarcinoma using CLDN18, CDH17, and pax8 in association with HPV status.
Asaka S; Nakajima T; Ida K; Asaka R; Kobayashi C; Ito M; Miyamoto T; Uehara T; Ota H
Virchows Arch; 2022 Feb; 480(2):269-280. PubMed ID: 34581850
[TBL] [Abstract] [Full Text] [Related]
13. Mesonephric-like adenocarcinoma of the ovary in an elderly woman: A case report and a review of the literature.
Ujita M; Abiko K; Kuwahara R; Emoto I; Amano Y; Konishi I
J Obstet Gynaecol Res; 2021 Dec; 47(12):4490-4495. PubMed ID: 34580958
[TBL] [Abstract] [Full Text] [Related]
14. Immunohistochemical and genetic characteristics of HPV-associated endocervical carcinoma with an invasive stratified mucin-producing carcinoma (ISMC) component.
Park E; Kim YT; Kim S; Nam EJ; Cho NH
Mod Pathol; 2021 Sep; 34(9):1738-1749. PubMed ID: 34103667
[TBL] [Abstract] [Full Text] [Related]
15. INI1-Deficient Thyroid Carcinoma is an Aggressive Disease with Epithelioid and Rhabdoid Phenotype. A Case Report, Survey of INI1 Expression in Thyroid Lesions and Literature Review.
Liu Z; Seshadri M; Gupta V; Papanicolau-Sengos A; Merzianu M
Head Neck Pathol; 2021 Dec; 15(4):1246-1252. PubMed ID: 34057693
[TBL] [Abstract] [Full Text] [Related]
16. Genetic variation in cervical preinvasive and invasive disease: a genome-wide association study.
Bowden SJ; Bodinier B; Kalliala I; Zuber V; Vuckovic D; Doulgeraki T; Whitaker MD; Wielscher M; Cartwright R; Tsilidis KK; Bennett P; Jarvelin MR; Flanagan JM; Chadeau-Hyam M; Kyrgiou M;
Lancet Oncol; 2021 Apr; 22(4):548-557. PubMed ID: 33794208
[TBL] [Abstract] [Full Text] [Related]
17. ER-positive endocervical adenocarcinoma mimicking endometrioid adenocarcinoma in morphology and immunohistochemical profile: A case report of application of HPV RNAscope detection.
Chen R; Qin P; Luo Q; Yang W; Tan X; Cai T; Jiang Q; Chen H
Medicine (Baltimore); 2021 Apr; 100(13):e24927. PubMed ID: 33787580
[TBL] [Abstract] [Full Text] [Related]
18. [Clinicopathological Features of Intrathyroid Thymic Carcinoma].
Zheng ZG; Sun WY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Feb; 43(1):42-46. PubMed ID: 33663661
[TBL] [Abstract] [Full Text] [Related]
19. [ANAPLASTIC TRANSFORMATION OF METASTATIC PAPILLARY THYROID CARCINOMA IN A cervical LYMPH NODE - A TIMELINE].
Horev Y; Vaknine H; Cinamon U
Harefuah; 2020 Nov; 159(11):809-814. PubMed ID: 33210851
[TBL] [Abstract] [Full Text] [Related]
20. Immunohistochemical expression of PAX-8 in Sudanese patients diagnosed with malignant female reproductive tract tumors.
Ali ET; Mohamed NS; Shafig IR; Muneer MS; Yosif AA; Hassan LA; Mohamed AM; Ahmed A; Siddig EE
BMC Res Notes; 2020 Aug; 13(1):396. PubMed ID: 32847623
[TBL] [Abstract] [Full Text] [Related]
[Next]